SURENDRA H BODAKHE

Dr. SURENDRA H BODAKHE


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Journal of Current Ophthalmology
Verified
Journal Article
Open access
RCRajesh Choudhary
Rajesh Choudhary
MKMandeep Singh Kapoor
Mandeep Singh Kapoor
ASAmrita Singh
Amrita Singh
SBSURENDRA H BODAKHE
SURENDRA H BODAKHE
To review current literature on the renin-angiotensin system (RAS)-mediated pathogenic mechanisms and therapeutic targets in ocular diseases. A comprehensive literature survey was performed on PubMed, Scopus, and Google Scholar databases published from 1977 to 2016. The search terms were a RAS, angiotensin, angiotensin receptor, prorenin, pro (renin) receptor, angiotensin converting enzyme inhibitor, angiotensin receptor blocker associated with ocular disorders like cataract, glaucoma, diabetic retinopathy (DR), macular degeneration, and uveitis. Articles were reviewed on the basis of the association between ocular disorders and RAS and relevant articles were discussed. The literature revealed that the individual RAS components including renin, angiotensins, angiotensin converting enzymes, and RAS receptors have been expressed in the specific ocular tissues like retina, choroid, and ciliary body. The activation of both circulatory and local RAS potentiate the various inflammatory and angiogenic signaling molecules, including vascular endothelial growth factor (VEGF), extracellular signal-regulated kinase, and advanced glycation end products (AGE) in the ocular tissues and leads to several blinding disorders like DR, glaucoma, and macular degeneration. The classical and newer RAS inhibitors have illustrated protective effects on blinding disorders, including DR, glaucoma, macular degeneration, uveitis, and cataract. The RAS components are present in the extrarenal tissues including ocular tissue and have an imperative role in the ocular pathophysiology. The clinical studies are needed to show the role of therapeutic modalities targeting RAS in the treatment of different ocular disorders.

1 September 2016 in Journal of Current Ophthalmology
Verified
Journal Article
Open access
SKSamsroz Ahmad Khan
Samsroz Ahmad Khan
RCRajesh Choudhary
Rajesh Choudhary
ASAmrita Singh
Amrita Singh
SBSURENDRA H BODAKHE
SURENDRA H BODAKHE
To evaluate modes of cataractogenesis in the hypertensive state by using different hypertensive animal models, including fructose, cadmium chloride (CdCl2), N ω-nitro-l-arginine methyl ester (l-NAME), and two-kidney, one clip (2K1C) method. Male Sprague-Dawley albino rats (150-180 g) were divided into different groups, each group containing six animals. Hypertension was induced in animals via six weeks administration of fructose (10% solution in drinking water), CdCl2 (0.5 mg/kg/day, i.p.), and l-NAME (20 mg/kg/day, p.o.) in their respective groups and NaCl (0.9% solution in drinking water) in the 2K1C group. The Ramipril-treated group (2 mg/kg/day, orally) served as a standard group for the 2K1C animal model. Blood pressure was measured biweekly using non-invasive blood pressure system. The biochemical parameters in serum and eye lenses were evaluated after six weeks of the experimental protocol. Hypertensive animal models showed significant induction of systolic and diastolic blood pressure and modulation of oxidative stress through depletion of antioxidants, including glutathione peroxidase, catalase, superoxide dismutase, glutathione, and elevation of malondialdehyde in serum and eye lenses. A significant elevation of ionic contents (Na(+) and Ca(2+)) and reduction of total protein and Ca(2+) ATPase activity in eye lenses were observed in all hypertensive animal models except l-NAME when compared with the normal group. The significant restoration of the antioxidants, Malondialdehyde (MDA) total protein, and ionic contents in the eye lenses concomitant with reduction of blood pressure were observed in the ramipril-treated group as compared to the 2K1C animal model. The results indicate that the fructose, CdCl2, and 2K1C models showed pronounced cataractogenic effects in the rat eye lenses. Based on our findings, it can be concluded that systemic hypertension significantly increases the risk of cataract formation in the rat eyes via modulation of the antioxidant defense mechanism and electrolyte homeostasis.

1 November 2015 in Journal of Pharmacological and Toxicological Methods
Verified
Journal Article
Closed access
MKMandeep Singh Kapoor
Mandeep Singh Kapoor
SKSamsroz Ahmad Khan
Samsroz Ahmad Khan
SGSanjay Kumar Gupta
Sanjay Kumar Gupta
RCRajesh Choudhary
Rajesh Choudhary
SBSURENDRA H BODAKHE
SURENDRA H BODAKHE

25 April 2025 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
YDYogita Dhurandhar
Yogita Dhurandhar
STShubham Tomar
Shubham Tomar
ADAshmita Das
Ashmita Das
JPJeevan Lal Prajapati
Jeevan Lal Prajapati
ASAs Pee Singh
As Pee Singh
KNKamta P. Namdeo
Kamta P. Namdeo

20 November 2019 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
ASAmrita Singh
Amrita Singh
SBSURENDRA H BODAKHE
SURENDRA H BODAKHE